Copyright Reports & Markets. All rights reserved.

Global and United States Preimplantation Genetics Diagnosis (PGD) Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Gender Selection
    • 1.2.3 Chromosomal Abnormalities
    • 1.2.4 Single Gene Disorders
    • 1.2.5 HLA Typing
    • 1.2.6 Aneuploidy
    • 1.2.7 X-Linked Diseases
    • 1.2.8 Other
  • 1.3 Market by Application
    • 1.3.1 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Perspective (2015-2026)
  • 2.2 Global Preimplantation Genetics Diagnosis (PGD) Growth Trends by Regions
    • 2.2.1 Preimplantation Genetics Diagnosis (PGD) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Preimplantation Genetics Diagnosis (PGD) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Market Size
    • 3.1.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Revenue (2015-2020)
    • 3.1.2 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Players (2015-2020)
  • 3.2 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Preimplantation Genetics Diagnosis (PGD) Revenue
  • 3.4 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio
    • 3.4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetics Diagnosis (PGD) Revenue in 2019
  • 3.5 Key Players Preimplantation Genetics Diagnosis (PGD) Area Served
  • 3.6 Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
  • 3.7 Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Type (2015-2026)

  • 4.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Type (2015-2020)
  • 4.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2021-2026)

5 Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Application (2015-2026)

  • 5.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Application (2015-2020)
  • 5.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2026)
  • 6.2 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 6.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)
  • 6.4 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2026)
  • 7.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 7.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)
  • 7.4 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2026)
  • 8.2 China Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 8.3 China Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)
  • 8.4 China Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2026)
  • 9.2 Japan Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 9.3 Japan Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)
  • 9.4 Japan Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2026)
  • 10.2 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Introduction
    • 11.1.4 Abbott Laboratories Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020))
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 Natera, Inc
    • 11.2.1 Natera, Inc Company Details
    • 11.2.2 Natera, Inc Business Overview
    • 11.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Introduction
    • 11.2.4 Natera, Inc Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 11.2.5 Natera, Inc Recent Development
  • 11.3 PerkinElmer
    • 11.3.1 PerkinElmer Company Details
    • 11.3.2 PerkinElmer Business Overview
    • 11.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Introduction
    • 11.3.4 PerkinElmer Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 11.3.5 PerkinElmer Recent Development
  • 11.4 Illumina
    • 11.4.1 Illumina Company Details
    • 11.4.2 Illumina Business Overview
    • 11.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Introduction
    • 11.4.4 Illumina Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 11.4.5 Illumina Recent Development
  • 11.5 F. Hoffmann-La Roche
    • 11.5.1 F. Hoffmann-La Roche Company Details
    • 11.5.2 F. Hoffmann-La Roche Business Overview
    • 11.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Introduction
    • 11.5.4 F. Hoffmann-La Roche Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 11.5.5 F. Hoffmann-La Roche Recent Development
  • 11.6 Thermo Fisher Scientific
    • 11.6.1 Thermo Fisher Scientific Company Details
    • 11.6.2 Thermo Fisher Scientific Business Overview
    • 11.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Introduction
    • 11.6.4 Thermo Fisher Scientific Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 11.6.5 Thermo Fisher Scientific Recent Development
  • 11.7 Laboratory Corporation of America Holdings
    • 11.7.1 Laboratory Corporation of America Holdings Company Details
    • 11.7.2 Laboratory Corporation of America Holdings Business Overview
    • 11.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Introduction
    • 11.7.4 Laboratory Corporation of America Holdings Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 11.7.5 Laboratory Corporation of America Holdings Recent Development
  • 11.8 Agilent Technologies
    • 11.8.1 Agilent Technologies Company Details
    • 11.8.2 Agilent Technologies Business Overview
    • 11.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Introduction
    • 11.8.4 Agilent Technologies Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 11.8.5 Agilent Technologies Recent Development
  • 11.9 Quest Diagnostics Incorporated
    • 11.9.1 Quest Diagnostics Incorporated Company Details
    • 11.9.2 Quest Diagnostics Incorporated Business Overview
    • 11.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Introduction
    • 11.9.4 Quest Diagnostics Incorporated Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 11.9.5 Quest Diagnostics Incorporated Recent Development
  • 11.10 Cooper Surgical
    • 11.10.1 Cooper Surgical Company Details
    • 11.10.2 Cooper Surgical Business Overview
    • 11.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Introduction
    • 11.10.4 Cooper Surgical Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 11.10.5 Cooper Surgical Recent Development
  • 11.11 Beijing Genomics Institute (BGI)
    • 10.11.1 Beijing Genomics Institute (BGI) Company Details
    • 10.11.2 Beijing Genomics Institute (BGI) Business Overview
    • 10.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Introduction
    • 10.11.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 10.11.5 Beijing Genomics Institute (BGI) Recent Development
  • 11.12 Genea Limited
    • 10.12.1 Genea Limited Company Details
    • 10.12.2 Genea Limited Business Overview
    • 10.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Introduction
    • 10.12.4 Genea Limited Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 10.12.5 Genea Limited Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Preimplantation Genetics Diagnosis (PGD) Scope and Market Size
    Preimplantation Genetics Diagnosis (PGD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetics Diagnosis (PGD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Gender Selection
    Chromosomal Abnormalities
    Single Gene Disorders
    HLA Typing
    Aneuploidy
    X-Linked Diseases
    Other

    Market segment by Application, split into
    Hospitals
    Clinics
    Other

    Based on regional and country-level analysis, the Preimplantation Genetics Diagnosis (PGD) market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Preimplantation Genetics Diagnosis (PGD) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott Laboratories
    Natera, Inc
    PerkinElmer
    Illumina
    F. Hoffmann-La Roche
    Thermo Fisher Scientific
    Laboratory Corporation of America Holdings
    Agilent Technologies
    Quest Diagnostics Incorporated
    Cooper Surgical
    Beijing Genomics Institute (BGI)
    Genea Limited

    Buy now